One prominent example is the receptor programmed cell death 1 (PD-1) and its ligand (PD-L1), which is a key inhibitor of anticancer T-cell responses in the tumor microenvironment (Freeman et al. 2000). This evidence concerns the gene PDCD1 and neoplasm.